A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
Incyte Corporation
JaxBio Ltd
Advice Pharma Group srl
Astellas Pharma Inc
Pfizer
Merck Sharp & Dohme LLC
Gamida Cell ltd
Bellicum Pharmaceuticals
Celgene
Mirror Biologics, Inc.
Celldex Therapeutics
Polyphor Ltd.
Celgene
INSYS Therapeutics Inc
Texas Oncology Cancer Center
Targazyme, Inc.
The Emmes Company, LLC
Accenture
Bristol-Myers Squibb